Volume 5, Issue 4 (Spring 2020)
SJNMP 2020, 5(4): 94-104 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rizevandi P, Alimohammadi E, Bagheri S R, Abdi A, Veisi H. The impact of preinjury consumption of antithrombotic drugs on clinical outcomes of patients with moderate to severe traumatic brain injury. SJNMP 2020; 5 (4) :94-104
URL: http://sjnmp.muk.ac.ir/article-1-312-en.html
URL: http://sjnmp.muk.ac.ir/article-1-312-en.html
1- Paramedical School, Kermanshah University of Medical Sciences
2- Department of neurosurgery, Kermanshah University of Medical Sciences ,hafez125@gmail.com
3- Neurosurgery Department, School of Medicine, Kermanshah University of Medical Sciences
4- Nursing and Midwifery School, Kermanshah University of Medical Sciences
5- Clinical Research Development Center of Imam Reza Hospital, Kermanshah University of Medical Sciences
2- Department of neurosurgery, Kermanshah University of Medical Sciences ,
3- Neurosurgery Department, School of Medicine, Kermanshah University of Medical Sciences
4- Nursing and Midwifery School, Kermanshah University of Medical Sciences
5- Clinical Research Development Center of Imam Reza Hospital, Kermanshah University of Medical Sciences
Abstract: (2435 Views)
Background & Aim: The main goal of the present study was to investigate the impact of preinjury intake of direct oral anticoagulants (DOACs), warfarin, and antiplatelet on clinical and radiological neuro-deterioration of patients with moderate to severe traumatic brain injury (TBI).
Materials & Methods: We investigated 224 consecutive patients more than 50 years old with moderate and severe TBI admitted to the Taleghani hospital, Kermanshah, Iran, between Jul 2014 and Jul 2019, retrospectively. Demographic, clinical, and laboratory data were retrospectively reviewed using the electronic medical records of all patients. Patients were categorized into four groups: nonuser patients, patients on platelet inhibitors, patients on warfarin and patients taking any DOACs. Clinical outcome was evaluated with the Glasgow Outcome Scale.
Results: 95 patients (42.4%) received no anti thrombotic drugs before the trauma. However, 69 patients (30.8%) were receiving platelet inhibitors, 42 subjects (18.8%) were on the warfarin, and 18 cases (8.0%) were on the DOACs before their trauma. There were 41 cases (18.3%) with in-hospital mortality. Our results showed that, 108 patients (48.2%) had a favorable outcome and 116 ones (51.8%) had an unfavorable outcome. Patients on Warfarin and those were receiving DOACs were associated with higher mortality as well as a more unfavorable clinical outcome (p<0.005).
Conclusion: Preinjury use of DOACs and warfarin is associated with higher mortality and worse clinical outcome. However, preinjury antiplatelet therapy did not contribute to in-hospital mortality and poor clinical outcomes.
Materials & Methods: We investigated 224 consecutive patients more than 50 years old with moderate and severe TBI admitted to the Taleghani hospital, Kermanshah, Iran, between Jul 2014 and Jul 2019, retrospectively. Demographic, clinical, and laboratory data were retrospectively reviewed using the electronic medical records of all patients. Patients were categorized into four groups: nonuser patients, patients on platelet inhibitors, patients on warfarin and patients taking any DOACs. Clinical outcome was evaluated with the Glasgow Outcome Scale.
Results: 95 patients (42.4%) received no anti thrombotic drugs before the trauma. However, 69 patients (30.8%) were receiving platelet inhibitors, 42 subjects (18.8%) were on the warfarin, and 18 cases (8.0%) were on the DOACs before their trauma. There were 41 cases (18.3%) with in-hospital mortality. Our results showed that, 108 patients (48.2%) had a favorable outcome and 116 ones (51.8%) had an unfavorable outcome. Patients on Warfarin and those were receiving DOACs were associated with higher mortality as well as a more unfavorable clinical outcome (p<0.005).
Conclusion: Preinjury use of DOACs and warfarin is associated with higher mortality and worse clinical outcome. However, preinjury antiplatelet therapy did not contribute to in-hospital mortality and poor clinical outcomes.
Type of Study: Research |
Subject:
Special
Received: 2020/03/16 | Revised: 2020/03/18 | Accepted: 2020/03/18 | Published: 2020/03/20 | ePublished: 2020/03/20
Received: 2020/03/16 | Revised: 2020/03/18 | Accepted: 2020/03/18 | Published: 2020/03/20 | ePublished: 2020/03/20
References
1. Falzon CM, Celenza A, Chen W, Lee G. Comparison of outcomes in patients with head trauma, taking preinjury antithrombotic agents. Emerg Med J. 2013;30(10):809-14. [DOI:10.1136/emermed-2012-201687]
2. Grandhi R, Harrison G, Voronovich Z, Bauer J, Chen SH, Nicholas D, et al. Preinjury warfarin, but not antiplatelet medications, increases mortality in elderly traumatic brain injury patients. J Trauma Acute Care Surg. 2015;78(3):614-21. [DOI:10.1097/TA.0000000000000542]
3. Hossri S, Ghanem S, Saouma S, Atanassov K. Impact of Preinjury Anticoagulation with Warfarin on Outcomes of Adult Trauma Patients: Experience of a Level 1 Trauma Center. Am Surg. 2017;83(6):e202-4.
4. Ahmed N, Bialowas C, Kuo YH, Zawodniak L. Impact of preinjury anticoagulation in patients with traumatic brain injury. South Med J. 2009;102(5):476-80. [DOI:10.1097/SMJ.0b013e31819f97a3]
5. Alsakha A, Guttman A. Traumatic intracranial hemorrhage in patients using warfarin or clopidogrel. Canad J Emergency Medicine. 2014;16(4):327-9. [DOI:10.2310/8000.2013.131000]
6. Blackmore AR, Caputo LM, Bourg PW, Mains CW. Developing, Implementing, and Evaluating a Nurse-Driven Rapid Reversal Protocol for Patients With Traumatic Intracerebral Hemorrhage in the Presence of Preinjury Warfarin. Journal of trauma nursing: J Trauma Nurs. 2016;23(3):138-43. [DOI:10.1097/JTN.0000000000000201]
7. Bonville DJ, Ata A, Jahraus CB, Arnold-Lloyd T, Salem L, Rosati C, et al. Impact of preinjury warfarin and antiplatelet agents on outcomes of trauma patients. Surgery. 2011;150(4):861-8. [DOI:10.1016/j.surg.2011.07.070]
8. Wood B, Nascimento B, Rizoli S, Sholzberg M, McFarlan A, Phillips A, et al. The Anticoagulated trauma patient in the age of the direct oral anticoagulants: a Canadian perspective. Scand J Trauma Resusc Emerg Med. 2017;25(1):76. [DOI:10.1186/s13049-017-0420-y]
9. Tollefsen MH, Vik A, Skandsen T, Sandrod O, Deane SF, Rao V, et al. Patients with Moderate and Severe Traumatic Brain Injury: Impact of Preinjury Platelet Inhibitor or Warfarin Treatment. World Neurosurg. 2018;114:e209-e17. [DOI:10.1016/j.wneu.2018.02.167]
10. Nishijima DK, Offerman SR, Ballard DW, Vinson DR, Chettipally UK, Rauchwerger AS, et al. Risk of traumatic intracranial hemorrhage in patients with head injury and preinjury warfarin or clopidogrel use. Am J Emerg Med. 2013;20(2):140-5. [DOI:10.1111/acem.12074]
11. Peck KA, Calvo RY, Schechter MS, Sise CB, Kahl JE, Shackford MC, et al. The impact of preinjury anticoagulants and prescription antiplatelet agents on outcomes in older patients with traumatic brain injury. J Trauma Acute Care Surg. 2014;76(2):431-6. [DOI:10.1097/TA.0000000000000107]
12. Narum S, Brors O, Stokland O, Kringen MK. Mortality among head trauma patients taking preinjury antithrombotic agents: a retrospective cohort analysis from a Level 1 trauma centre. BMC Emerg Med. 2016;16(1):29. [DOI:10.1186/s12873-016-0094-1]
13. Reddy S, Sharma R, Grotts J, Ferrigno L, Kaminski S. Incidence of intracranial hemorrhage and outcomes after ground-level falls in geriatric trauma patients taking preinjury anticoagulants and antiplatelet agents. Am Surg. 2014;80(10):975-8.
14. Smith K, Weeks S. The impact of pre-injury anticoagulation therapy in the older adult patient experiencing a traumatic brain injury: A systematic review. JBI library of systematic reviews. 2012;10(58):4610-21. [DOI:10.11124/jbisrir-2012-429]
15. Nishijima DK, Shahlaie K, Sarkar K, Rudisill N, Holmes JF. Risk of unfavorable long-term outcome in older adults with traumatic intracranial hemorrhage and anticoagulant or antiplatelet use. Am J Emerg Med. 2013;31(8):1244-7. [DOI:10.1016/j.ajem.2013.04.035]
16. Myers SP, Dadashzadeh ER, Cheung J, Alarcon L, Kutcher M, Brown JB, et al. Management of anticoagulation with rivaroxaban in trauma and acute care surgery: Complications and reversal strategies as compared to warfarin therapy. J Trauma Acute Care Surg. 2017;82(3):542-9. [DOI:10.1097/TA.0000000000001340]
17. Pozzessere A, Grotts J, Kaminski S. Dabigatran Use Does Not Increase Intracranial Hemorrhage in Traumatic Geriatric Falls When Compared with Warfarin. Am Surg. 2015;81(10):1039-42.
18. Kudo D, Kushimoto S, Shiraishi A, Ogura H, Hagiwara A, Saitoh D. The impact of preinjury antithrombotic medication on hemostatic interventions in trauma patients. Am J Emerg Med. 2017;35(1):62-5. [DOI:10.1016/j.ajem.2016.10.002]
19. Miller J, Lieberman L, Nahab B, Hurst G, Gardner-Gray J, Lewandowski A, et al. Delayed intracranial hemorrhage in the anticoagulated patient: A systematic review. J Trauma Acute Care Surg. 2015;79(2):310-3. [DOI:10.1097/TA.0000000000000725]
20. Stein SC, Spettell C. The Head Injury Severity Scale (HISS): a practical classification of closed-head injury. Brain Inj. 1995;9(5):437-44. [DOI:10.3109/02699059509008203]
21. Pang CH, Lee SE, Yoo H. Clinical Factors and Perioperative Strategies Associated with Outcome in Preinjury Antiplatelet and Anticoagulation Therapy for Patients with Traumatic Brain Injuries. J Korean Neurosurg Soc. 2015;58(3):262-70. [DOI:10.3340/jkns.2015.58.3.262]
22. Marcia L, Moazzez A, Plurad DS, Putnam B, Kim DY. Utility of Repeat Head CT in Patients on Preinjury Antithrombotic Medications. Am Surg. 2018;84(10):1626-9.
23. Major J, Reed MJ. A retrospective review of patients with head injury with coexistent anticoagulant and antiplatelet use admitted from a UK emergency department. Emerg Med J. 2009; 26(12):871-6. [DOI:10.1136/emj.2008.068643]
24. Nishijima DK, Offerman SR, Ballard DW, Vinson DR, Chettipally UK, Rauchwerger AS, et al. Immediate and delayed traumatic intracranial hemorrhage in patients with head trauma and preinjury warfarin or clopidogrel use. Ann Emerg Med. 2012;59(6):460-8.e1-7. [DOI:10.1016/j.annemergmed.2012.04.007]
25. Fabbri A, Servadei F, Marchesini G, Bronzoni C, Montesi D, Arietta L. Antiplatelet therapy and the outcome of subjects with intracranial injury: the Italian SIMEU study. Crit Care. 2013;17(2):R53. [DOI:10.1186/cc12575]
26. Kobayashi L, Barmparas G, Bosarge P, Brown CV, Bukur M, Carrick MM, et al. Novel oral anticoagulants and trauma: The results of a prospective American Association for the Surgery of Trauma Multi-Institutional Trial. J Trauma Acute Care Surg. 2017;82(5):827-35. [DOI:10.1097/TA.0000000000001414]
27. Maung AA, Bhattacharya B, Schuster KM, Davis KA. Trauma patients on new oral anticoagulation agents have lower mortality than those on warfarin. J Trauma Acute Care Surg. 2016;81(4):652-7. [DOI:10.1097/TA.0000000000001189]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
